ARTICLES BY MATHINI ILANCHERAN
-
Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development10/21/2025
Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.
-
100% U.S. Drug Tariffs: Implications For Pharma And Outsourcing10/17/2025
Research Manager Mathini Ilancheran explores the effects of U.S. drug tariffs on global supply chains, multinational pharma firms, and critical partners across drug development.